Published by Abigail Townsend on 8th June 2021
(Sharecast News) - Shares in Biogen closed nearly 40% higher after the biotech's breakthrough Alzheimer's drug received regulatory approval in the US.
URL: http://www.digitallook.com/dl/news/story/31903086/...